Home » Topics » Regulatory » Patents

Patents
RSS

Chinese researchers patent sigma-1 receptor agonists

Jan. 24, 2022

BioWorld MedTech Patent Highlights: Week 2

From Current Patent Gazette

Jan. 21, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

4E Therapeutics discloses new MNK1 and/or MNK2 inhibitors

Jan. 21, 2022

New three-prime repair exonuclease 1 inhibitors described by Tempest Therapeutics

Jan. 21, 2022

Scripps Research Institute, ShangPharma Innovation patent Rev-erbA-alpha/beta agonists

Jan. 21, 2022

New macrophage migration inhibitory factor inhibitors identified at Immunophage Biomedical

Jan. 21, 2022

New TRPA1 antagonists discovered at Boehringer Ingelheim

Jan. 21, 2022

Red Bull GmbH presents dopamine reuptake inhibitors

Jan. 20, 2022

Medshine Discovery synthesizes new JAK3 inhibitors

Jan. 20, 2022

Sun Pharmaceutical Industries divulges GIPR and GLP-1 receptor dual agonists

Jan. 20, 2022

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...